Posted BY: Bill | NwoReport
A Covid vaccine maker that received clinical trial approvals from the National Institute of Allergy and Infectious Disease (NIAID), formerly headed by Dr. Anthony Fauci, has just paid $400 million to the “public health” organization.
The cash windfall that Moderna recently paid the NIAID was reported by the industry watchdog group Fierce Pharma.
“In Moderna’s earnings release Thursday, the company said it recently paid the National Institute of Allergy and Infectious Diseases (NIAID) a $400 million ‘catch-up payment’ under a new royalty-bearing license agreement between the parties,” the report noted.
“The payment is part of a license agreement between Moderna and NIAID inked late last year. With the deal, Moderna is paying the U.S. government to access ‘certain patent rights concerning stabilizing prefusion coronavirus spike proteins,’” the report added, citing Moderna Chief Financial Officer Jamie Mock.
Trending: Holy Grail of COVID-19 Spike Protein Detoxification
Moderna agreed to pay NIAID “low single-digit royalties” on COVID-19 vaccine sales moving forward, Mock added.
